Stock Traders Purchase High Volume of Call Options on Johnson & Johnson (JNJ)
Johnson & Johnson (NYSE:JNJ) was the recipient of some unusual options trading on Tuesday. Stock investors bought 14,710 call options on the company, American Banking News reports. This is an increase of approximately 114% compared to the average daily volume of 6,862 call options.
A number of research firms have recently commented on JNJ. Analysts at Zacks reiterated a “neutral” rating on shares of Johnson & Johnson in a research note to investors on Friday, August 30th. They now have a $91.00 price target on the stock. Separately, analysts at Thomson Reuters/Verus upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating in a research note to investors on Monday, August 12th. Finally, analysts at Thomson Reuters/Verus downgraded shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a research note to investors on Monday, July 22nd. Three analysts have rated the stock with a sell rating, six have issued a hold rating and eight have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $87.77.
Shares of Johnson & Johnson (NYSE:JNJ) traded down 1.13% during mid-day trading on Tuesday, hitting $85.61. 8,670,018 shares of the company’s stock traded hands. Johnson & Johnson has a 52 week low of $67.80 and a 52 week high of $94.42. The stock has a 50-day moving average of $87.91 and a 200-day moving average of $87.03. The company has a market cap of $241.3 billion and a price-to-earnings ratio of 19.22.
Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings results on Tuesday, July 16th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.09. The company had revenue of $17.90 billion for the quarter, compared to the consensus estimate of $17.71 billion. During the same quarter in the previous year, the company posted $1.30 earnings per share. The company’s revenue for the quarter was up 8.5% on a year-over-year basis. On average, analysts predict that Johnson & Johnson will post $5.46 earnings per share for the current fiscal year.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.